Nanobiotix (NBTX) Current Assets (2018 - 2025)

Nanobiotix (NBTX) has 8 years of Current Assets data on file, last reported at $73.0 million in Q4 2025.

• In Q4 2025, Current Assets rose 11.21% year-over-year to $73.0 million; the TTM figure through Dec 2025 stood at $73.0 million (up 11.21% YoY), while the FY2025 annual figure was $70.9 million, up 6.57% from the prior year.
• Current Assets climbed to $73.0 million in Q4 2025, from $65.7 million in the prior quarter.
• Across five years, Current Assets topped out at $106.5 million in Q4 2021 and bottomed at $53.4 million in Q4 2022.
• A 5-year average of $78.5 million and a median of $73.0 million in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets tumbled 49.82% — and 2023, when it surged 75.92%.
• Year by year, Current Assets stood at $106.5 million in 2021, then slumped by 49.82% to $53.4 million in 2022, then soared by 75.92% to $94.0 million in 2023, then sank by 30.1% to $65.7 million in 2024, then gained by 11.21% to $73.0 million in 2025.
• The last three Current Assets figures came in at $73.0 million (Q4 2025), $65.7 million (Q4 2024), and $94.0 million (Q4 2023), per Business Quant data.

Peer Comparison